Related references
Note: Only part of the references are listed.Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
Cunte Chen et al.
FRONTIERS IN PHARMACOLOGY (2021)
Expression patterns of immune checkpoints in acute myeloid leukemia
Cunte Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Novel immunomodulatory drugs and neo-substrates
Shaobing Gao et al.
BIOMARKER RESEARCH (2020)
LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
Rui Huang et al.
BIOMARKER RESEARCH (2020)
Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia
Jifeng Yu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it
Amer M. Zeidan et al.
BLOOD REVIEWS (2019)
Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression
Paola Montes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies
Cong Wang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Immune Mechanisms in Myelodysplastic Syndrome
Andreas Glenthoj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients
Isabelle Bartram et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Comparison of the Distribution and Clonal Expansion Features of the T-Cell γδ Repertoire in Myelodysplastic Syndrome-RAEB and RAEB with Progression to AML
Suxia Geng et al.
DNA AND CELL BIOLOGY (2012)
Share Paper
